These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33747950)

  • 1. Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries.
    Oppelt KA; Kuiper JG; Ingrasciotta Y; Ientile V; Herings RMC; Tari M; Trifirò G; Haug U
    Front Oncol; 2021; 11():630456. PubMed ID: 33747950
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project.
    Ingrasciotta Y; Spini A; L'Abbate L; Fiore ES; Carollo M; Ientile V; Isgrò V; Cavazzana A; Biasi V; Rossi P; Ejlli L; Belleudi V; Poggi F; Sapigni E; Puccini A; Ancona D; Stella P; Pollina Addario S; Allotta A; Leoni O; Zanforlini M; Tuccori M; Gini R; Trifirò G
    Pharmacol Res; 2024 Feb; 200():107074. PubMed ID: 38232909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in baseline characteristics between type 2 diabetes mellitus patients treated with dipeptidyl peptidase-4 inhibitors in randomized controlled trials and those receiving the same treatment in real-world settings
.
    Kostev K; Schokker E; Jacob L
    Int J Clin Pharmacol Ther; 2018 Sep; 56(9):411-416. PubMed ID: 30049306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China.
    Xu R; Wang W; Zhu B; Lin X; Ma D; Zhu L; Zhao Q; Nie Y; Cai X; Li Q; Fang W; Li H; Wang N; Chen Y; Peng C; Fang H; Shen L
    BMC Cancer; 2020 Feb; 20(1):131. PubMed ID: 32070312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials.
    Ziemssen F; Feltgen N; Holz FG; Guthoff R; Ringwald A; Bertelmann T; Wiedon A; Korb C;
    BMC Ophthalmol; 2017 Jan; 17(1):7. PubMed ID: 28103831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnitude of the Age-Advancement Effect of Comorbidities in Colorectal Cancer Prognosis.
    Boakye D; Walter V; Jansen L; Martens UM; Chang-Claude J; Hoffmeister M; Brenner H
    J Natl Compr Canc Netw; 2020 Jan; 18(1):59-68. PubMed ID: 31910379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents.
    Bronckers IMGJ; Paller AS; West DP; Lara-Corrales I; Tollefson MM; Tom WL; Hogeling M; Belazarian L; Zachariae C; Mahé E; Siegfried E; Blume-Peytavi U; Szalai Z; Vleugels RA; Holland K; Murphy R; Puig L; Cordoro KM; Lambert J; Alexopoulos A; Mrowietz U; Kievit W; Seyger MMB;
    JAMA Dermatol; 2020 Apr; 156(4):384-392. PubMed ID: 32022846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.
    Tappenden P; Jones R; Paisley S; Carroll C
    Health Technol Assess; 2007 Mar; 11(12):1-128, iii-iv. PubMed ID: 17346499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.
    Li N; Betts KA; Messali AJ; Skup M; Garg V
    Clin Ther; 2017 Aug; 39(8):1618-1627. PubMed ID: 28729087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It's contrary - comorbidity does not affect survival of South Africans with colorectal cancer: An analysis from the Colorectal Cancer in South Africa cohort.
    Bouter C; Bebington B; Maphosa S; Maher H; Gaylard P; Etheredge HR; Fabian J; Prodehl L; Surridge D; Fourie RL; Harran N; Lutrin D; Bizos D; Ruff P
    S Afr Med J; 2020 Apr; 110(5):382-388. PubMed ID: 32657722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Survival of Biological Therapies for Psoriasis Treatment in Germany and Associated Costs: A Retrospective Claims Database Analysis.
    Mahlich J; Alba A; Hadad LE; Leisten MK; Peitsch WK
    Adv Ther; 2019 Jul; 36(7):1684-1699. PubMed ID: 31102203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costs.
    Dignass A; Waller J; Cappelleri JC; Modesto I; Kisser A; Dietz L; DiBonaventura M; Wood R; May M; Libutzki B; Bargo D
    J Med Econ; 2020 Apr; 23(4):415-427. PubMed ID: 31858853
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis.
    Wu JJ; Pelletier C; Ung B; Tian M
    J Med Econ; 2019 Apr; 22(4):365-371. PubMed ID: 30652520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Chemotherapy With or Without Biologics Including Antiangiogenics and Monoclonal Antibodies Targeting EGFR and EpCAM in Colorectal Cancer: A Systematic Review and Meta-analysis.
    Serrano PE; Carter DN; Li C; Valencia M; Ruo L; Parpia S; Simunovic M; Levine O
    J Surg Res; 2019 Jul; 239():14-21. PubMed ID: 30782542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of First-Line Bevacizumab in Metastatic Colorectal Cancer: The Observational Cohort Study GRETA.
    Franchi M; Barni S; Tagliabue G; Ricci P; Mazzucco W; Tumino R; Caputo A; Corrao G;
    Oncologist; 2019 Mar; 24(3):358-365. PubMed ID: 30097524
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.